Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line
- 18 June 2003
- journal article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 10 (7) , 808-822
- https://doi.org/10.1038/sj.cdd.4401248
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Curing metastatic testicular cancerProceedings of the National Academy of Sciences, 2002
- Apoptosis and therapyThe Journal of Pathology, 1999
- Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell linesBritish Journal of Cancer, 1998
- Chemosensitivity of solid tumor cellsin vitro is related to activation of the CD95 systemInternational Journal of Cancer, 1998
- Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.Journal of Clinical Investigation, 1997
- Chemotherapy-Induced ApoptosisPublished by Elsevier ,1997
- Cellular basis for differential sensitivity to cisplatin in human germ cell tumour and colon carcinoma cell linesBritish Journal of Cancer, 1995
- Programmed cell death in response to chemotherapeutic agents in human germ cell tumour linesEuropean Journal Of Cancer, 1995
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994
- Hypersensitivity of human testis‐tumour cell lines to chemotherapeutic drugsInternational Journal of Cancer, 1993